Here’s a roundup of the latest coronavirus-related news.
Pfizer and BioNTech announced topline results from an analysis spanning through March 13, which in part showed their COVID-19 vaccine to be 91.3% effective against the virus for up to 6 months after the second dose.
Pfizer/BioNTech has just released their topline data from their Phase 3 study of participants aged 12 to 15 years.
A retrospectively analysis assessed the effect of a remote vaccination review process on vaccination status during the COVID-19 pandemic.
A team of researchers have released study results that show the Moderna and Pfizer vaccines are indeed safe and effective for this population.
The Minnesota PBM says it will pay $40 for a single-dose vaccine and $80 for a two-dose one. The company says it has paid pharmacies a total of $29 million in COVID-19 vaccine administration fees so far.